Bilateral rectus sheath haematoma complicating dengue virus infection in a patient on warfarin for mechanical aortic valve replacement: a case report
Authors:
- Chamith Thushanga RosaCRChamith Thushanga Rosa
- Mitrakrishnan Rayno NavinanMNMitrakrishnan Rayno Navinan
- Sincy SamarawickramaSSSincy Samarawickrama
- Himam HamzaHHHimam Hamza
- Maheshika GunarathneMGMaheshika Gunarathne
- Arulprashanth ArulananthamAAArulprashanth Arulanantham
- Neeha SubbaNSNeeha Subba
- Udari SamarasiriUSUdari Samarasiri
- Thushara MathiasTMThushara Mathias
- Aruna KulatungaAKAruna Kulatunga
Open Access
- 7 January 2017
- journal article
- case report
- Published by Springer Nature in BMC Research Notes
- Vol. 10 (1) , 1-6
Abstract
The management of Dengue virus infection can be challenging. Varied presentations and numerous complications intrinsic to dengue by itself increase the complexity of treatment and potential mortality. When burdened with the presence of additional comorbidities and the need to continue compulsory medications, clear stepwise definitive guidance is lacking and patients tend to have more complex complications and outcomes calling to question the clinical decisions that may have been taken. The use and continuation of warfarin in dengue virus infection is one such example. We report a 65 year old South Asian female who presented with dengue fever. She had a history bronchial asthma, a prior abdominal surgery, and was on warfarin and maintained a therapeutically appropriate internationalized normalized ratio for a mechanical aortic valve replacement. Though preemptive decision to stop warfarin was taken with decreasing platelet counts, her clinical course was complicated with the development of bilateral rectus sheath haematoma’s requiring resuscitation with blood transfusions. Though management of dengue viral fever has seen drastic evolution with recent updated guidance, clinical scenarios seen in the course of the illness still pose challenges to the managing physician. The need to continue obligatory anticoagulation which may seem counterintuitive during a complex disease such as dengue virus infection must be considered after understanding the potential risks versus that of its benefits. Though case by case decisions maybe warranted, a clear protocol would be very helpful in making clinical decisions, as the correct preemptive decision may potentially avert catastrophic and unpredictable bleeding events.Keywords
This publication has 19 references indexed in Scilit:
- Spontaneous rectus sheath hematoma associated with low dose of acetylsalicylic acidABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo), 2014
- Rectus sheath hematoma in a single secondary care institution: a retrospective studyHernia, 2013
- Dengue hemorrhagic fever and severe thrombocytopenia in a patient on mandatory anticoagulation; balancing two life threatening conditions; a case reportBMC Infectious Diseases, 2012
- Guidelines on oral anticoagulation with warfarin – fourth editionBritish Journal of Haematology, 2011
- Clinical Manifestations and Management of Dengue/DHF/DSSTropical Medicine and Health, 2011
- Bilateral Rectus Sheath Hematoma Developing During Anticoagulant TherapyCirculation, 2010
- Clinical factors influencing normalization of prothrombin time after stopping warfarin: a retrospective cohort studyThrombosis Journal, 2008
- Dengue: manifestações cardíacas e implicações na terapêutica antitrombóticaArquivos Brasileiros de Cardiologia, 2007
- Rectus Sheath Haematoma Associated with Low Molecular Weight Heparin: A Case SeriesThe Annals of The Royal College of Surgeons of England, 2007
- Haematology in dengue and dengue haemorrhagic feverBest Practice & Research Clinical Haematology, 2000